Search results for “Thrombin receptor antagonist” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 551 patents, we discovered top 28 key players by total patent application. Schering Corp., Merck Sharp & Dohme Corp., McNeil Pharmaceutical are dominant in this area. They take 74.05% of the total patent filing.
New Jersey, United States
Patent: 251
New Jersey, United States
Patent: 126
United States
Patent: 31
New Jersey, United States
Patent: 22
Mississippi, United States
Patent: 20
Berlin, Germany
Patent: 18
California, United States
Patent: 18
Tokyo-to, Japan
Patent: 12
Antwerpen, Belgium
Patent: 9
California, United States
Patent: 9
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 4 patents applied in the last 5 years. We discover 1 most active companies in this area.
Heilongjiang Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 4 patents in last 5 years, we discover 1 new entrants.
Heilongjiang Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 16 patents, we discovered top 2 universities and scientific research institutions by total patent application.
Fukuoka-ken, Japan
Patent: 8
Heilongjiang Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: